Richard S. D'Agostino
Lahey Hospital & Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Richard S. D'Agostino.
The Annals of Thoracic Surgery | 1996
Richard S. D'Agostino; Lars G. Svensson; Deborah J. Neumann; Husam H. Balkhy; Warren A. Williamson; David M. Shahian
BACKGROUND The role of noninvasive carotid artery screening in relation to other clinical variables in identifying patients at increased risk of stroke after coronary artery bypass grafting was examined. METHODS Preoperative, intraoperative, and postoperative clinical data were prospectively collected for 1,835 consecutive patients undergoing first-time isolated coronary artery bypass grafting between March 1990 and July 1995, 1,279 of whom had screening carotid ultrasonography. All patients with postoperative neurologic events were identified and reviewed in detail. Average patient age was 65.3 years (range, 33 to 92 years), and 9.3% (171 patients) had a prior permanent stroke or transient ischemic attack. Hospital and 30-day mortality was 2.2% (41 patients). Forty-five patients (2.5%) had a transient or permanent postoperative neurologic event. The data were analyzed by stepwise logistic regression to determine the independent predictors of both significant carotid stenosis and stroke. RESULTS On multivariate analysis, the clinical predictors of significant carotid stenosis were age (p < 0.0001), diabetes (p = 0.0123), female sex (p = 0.0026), left main coronary stenosis greater than 60% (p < 0.0001), prior stroke or transient ischemic attack (p = 0.0008), peripheral vascular disease (p = 0.0001), prior vascular operation (p = 0.0068), and smoking (p < 0.0001). When all variables were evaluated for those patients who underwent noninvasive carotid artery screening, the independent predictors of postoperative neurologic event were prior stroke or transient ischemic attack (p < 0.0001), peripheral vascular disease (p = 0.0037), postinfarction angina pectoris (p = 0.0319), postoperative atrial fibrillation (p = 0.0014), carotid stenosis greater than 50% (p = 0.0029), cardiopulmonary bypass time (p = 0.0006), significant aortic atherosclerosis (p = 0.0054), postoperative amrinone or epinephrine use (p = 0.0054), and left ventricular ejection fraction less than 0.30 (p = 0.0744). CONCLUSIONS The etiology of postoperative stroke is multifactorial. Selective use of carotid ultrasonography is of value in identifying patients who are at greater risk of postoperative stroke independent of other variables and should be considered before coronary artery bypass grafting, particularly in patients with a history of neurologic event or peripheral vascular disease.
The Annals of Thoracic Surgery | 1998
Lars G. Svensson; Kenneth R. Hess; Richard S. D'Agostino; Michael H. Entrup; Kinan Hreib; Wendy A. Kimmel; Edward Nadolny; David M. Shahian
BACKGROUND Of all aortic operations, thoracoabdominal aortic repairs have the highest risk of spinal cord neurologic injury, manifest by lower limb paraplegia or paraparesis. Cerebrospinal fluid drainage combined with intrathecal papaverine (CSFDr + IP) may reduce the risk and severity of neurologic injury. The objective of this study was to evaluate the effect of CSFDr + IP to prevent neurologic injury after high-risk thoracoabdominal aneurysm repairs. METHODS We screened 64 patients before operation with descending thoracic or thoracoabdominal aneurysms for possible inclusion in a prospective, randomized study. Thirty-three patients with high-risk type I and II thoracoabdominal aneurysms met inclusion criteria and 17 were randomly assigned to CSFDr + IP and 16 to the control group. The study was terminated early after interim analysis revealed a significant difference. RESULTS Of 64 patients screened, 2 patients died after operation (3.1%, 2/64); both were in the randomized study (6%, 2/33), and neither had a neurologic injury. Neurologic injury developed in 2 CSFDr + IP patients and 7 control patients (p = 0.0392). Control patients also had lower postoperative motor strength scores (p = 0.0340). On multivariate analysis, risk factors for neurologic injury included (p < 0.05) longer cross-clamp time, failure to actively cool with bypass, and postoperative hypotension, whereas CSFDr + IP was protective. Logistic regression showed that CSFDr + IP and active cooling significantly reduced the risk of injury and that the two combined modalities were additive. Of 64 patients screened, only 2 (3%) had a permanent neurologic deficit preventing ambulation. CONCLUSIONS For high-risk thoracoabdominal aneurysms, CSFDr + IP was effective in reducing the incidence and severity of neurologic injury. Active cooling may be further additive to CSFDr + IP protection, although this needs to be confirmed in a larger study.
The Annals of Thoracic Surgery | 2013
Lars G. Svensson; David H. Adams; Robert O. Bonow; Nicholas T. Kouchoukos; D. Craig Miller; Patrick T. O'Gara; David M. Shahian; Hartzell V. Schaff; Cary W. Akins; Joseph E. Bavaria; Eugene H. Blackstone; Tirone E. David; Nimesh D. Desai; Todd M. Dewey; Richard S. D'Agostino; Thomas G. Gleason; Katherine B. Harrington; Susheel Kodali; Samir Kapadia; Martin B. Leon; Brian Lima; Bruce W. Lytle; Michael J. Mack; T. Brett Reece; George R. Reiss; Eric E. Roselli; Craig R. Smith; Vinod H. Thourani; E. Murat Tuzcu; John Webb
The Society of Thoracic Surgeons Clinical Practice Guidelines are intended to assist physicians and other health care providers in clinical decision making by describing a range of generally acceptable approaches for the diagnosis, management, or prevention of specific diseases or conditions. These guidelines should not be considered inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the same results. Moreover, these guidelines are subject to change over time, without notice. The ultimate judgment regarding the care of a particular patient must be made by the physician in light of the individual circumstances presented by the patient.
The Annals of Thoracic Surgery | 2016
Richard S. D'Agostino; Jeffrey P. Jacobs; Vinay Badhwar; Gaetano Paone; J. Scott Rankin; Jane M. Han; Donna McDonald; Fred H. Edwards; David M. Shahian
The Society of Thoracic Surgeons Adult Cardiac Database is one of the longest-standing, largest, and most highly regarded clinical data registries in health care. It serves as the foundation for all quality measurement and improvement activities of The Society of Thoracic Surgeons. This report summarizes current aggregate national outcomes in adult cardiac surgery and reviews database-related activities in the areas of quality measurement and performance improvement.
The Annals of Thoracic Surgery | 2015
Jeffrey P. Jacobs; David M. Shahian; Richard L. Prager; Fred H. Edwards; Donna McDonald; Jane M. Han; Richard S. D'Agostino; Marshall L. Jacobs; Benjamin D. Kozower; Vinay Badhwar; Vinod H. Thourani; Henning A. Gaissert; Felix G. Fernandez; Cam Wright; James I. Fann; Gaetano Paone; Juan A. Sanchez; Joseph C. Cleveland; J. Matthew Brennan; Rachel S. Dokholyan; Sean M. O’Brien; Eric D. Peterson; Frederick L. Grover; G. Alexander Patterson
The Society of Thoracic Surgeons (STS) National Database is the foundation for most of the Societys quality, research, and patient safety activities. Beginning in January 2016 and repeating each year, The Annals of Thoracic Surgery will publish a monthly Database series of scholarly articles on outcomes analysis, quality improvement, and patient safety. Six articles will be directly derived from the STS National Database and will be published every other month: three articles on outcomes and quality (one each from the STS Adult Cardiac Surgery Database, the STS Congenital Heart Surgery Database, and the STS General Thoracic Surgery Database), and three articles on research (one from each of these three specialty databases). These six articles will alternate with five additional articles on topics related to patient safety. The final article, to be published in December, will provide a summary of the prior 11 manuscripts. This series will allow STS and its Workforces on National Databases, Research Development, and Patient Safety to convey timely information aimed at improving the quality and safety of cardiothoracic surgery.
The Journal of Thoracic and Cardiovascular Surgery | 2014
Xiaosai Yao; Christina Williamson; Viktor A. Adalsteinsson; Richard S. D'Agostino; Torin Fitton; Gregory G. Smaroff; Robert T. William; K. Dane Wittrup; J. Christopher Love
OBJECTIVE Intraoperative tumor shedding may facilitate tumor dissemination. In earlier studies, shed tumor cells were defined primarily by cytomorphological examination, and normal epithelial cells could not always be distinguished from tumor cells. We sought to accurately identify tumor cells using single-cell sequencing and determine whether these cells were mobilized into the circulation during pulmonary lobectomy. METHODS Forty-two blood samples collected from the tumor-draining pulmonary vein at the end of lobectomy procedures were analyzed. Arrays of nanowells were used to enumerate and retrieve single EpCAM(+) cells. Targeted sequencing of 10 to 15 cells and nested polymerase chain reaction of single cells detected somatic mutations in shed epithelial cells consistent with patient-matched tumor but not normal tissue. RESULTS The mean number of EpCAM(+) cells in video-assisted thoracoscopy (VATS) lobectomy (no wedge) specimens (n = 16) was 165 (median, 115; range, 0-509) but sampling cells from 3 patients indicated that only 0% to 38% of the EpCAM(+) cells were tumor cells. The mean number of EpCAM(+) cells in VATS lobectomy (wedge) specimens (n = 12) was 1128 (median, 197; range, 47-9406) and all of the EpCAM(+) cells were normal epithelial cells in 2 patients sampled. The mean number of EpCAM(+) cells in thoracotomy specimens (n = 14) was 238 (median, 22; range, 9-2920) and 0% to 50% of total EpCAM(+) cells were tumor cells based on 4 patients sampled. CONCLUSIONS Surgery mobilizes tumor cells into the pulmonary vein, along with many normal epithelial cells. EpCAM alone cannot differentiate between normal and tumor cells. On the other hand, single-cell genetic approaches with patient-matched normal and tumor tissues can accurately quantify the number of shed tumor cells.
The Journal of Thoracic and Cardiovascular Surgery | 2016
Christina Williamson; Lori B. Sheehan; David M. Venesy; Richard S. D'Agostino
From the Department of Thoracic and Cardiovascular Surgery, Lahey Hospital and Medical, Center, Burlington, Mass; the Department of Anesthesiology, Lahey Hospital andMedical, Center, Burlington, Mass; and the Department of Cardiology, Lahey Hospital and Medical Center, Burlington, Mass. Disclosures: Authors have nothing to disclose with regard to commercial support. Received for publication Aug 14, 2015; revisions received Sept 15, 2015; accepted for publication Sept 22, 2015; available ahead of print Oct 26, 2015. Address for reprints: Christina Williamson, MD, Department of Thoracic and Cardiovascular Surgery, Lahey Hospital and Medical Center, 41 Mall Rd, Burlington, MA 01805 (E-mail: [email protected]). J Thorac Cardiovasc Surg 2016;151:e1-3 0022-5223/
The Journal of Thoracic and Cardiovascular Surgery | 1995
David M. Shahian; Warren A. Williamson; Lars G. Svensson; Richard S. D'Agostino; David Martin; Jonathan R. Ellis; Ferdinand J. Venditti
36.00 Copyright 2016 by The American Association for Thoracic Surgery http://dx.doi.org/10.1016/j.jtcvs.2015.09.091 Transaortic view of left ventricular apical thrombus.
The Annals of Thoracic Surgery | 2004
Lars G. Svensson; Kyung Hwan Kim; Eugene H. Blackstone; Joan M. Alster; Patrick M. McCarthy; Roy K. Greenberg; Joseph F. Sabik; Richard S. D'Agostino; Bruce W. Lytle; Delos M. Cosgrove
The hypothesis that transvenous implantation of a cardioverter-defibrillator is associated with less morbidity than use of a transthoracic approach was investigated in a retrospective series of 146 patients. None of these patients had concomitant heart procedures, and the preoperative characteristics of the two groups were similar. When analyzed by actual technique used (transvenous, 57 patients; transthoracic, 89 patients) and by the intention-to-treat method (transvenous, 65 patients, 8 of whom actually underwent thoracotomy; thoracotomy, 81 patients), transvenous implantation was associated with a lower incidence of postoperative respiratory complications and atrial fibrillation. Total cardiac mortality and freedom from sudden cardiac death in the transvenous and transthoracic groups were comparable at 2 years.
The Annals of Thoracic Surgery | 2013
Lars G. Svensson; David H. Adams; Robert O. Bonow; Nicholas T. Kouchoukos; D. Craig Miller; Patrick T. O'Gara; David M. Shahian; Hartzell V. Schaff; Cary W. Akins; Joseph E. Bavaria; Eugene H. Blackstone; Tirone E. David; Nimesh D. Desai; Todd M. Dewey; Richard S. D'Agostino; Thomas G. Gleason; Katherine B. Harrington; Susheel Kodali; Samir Kapadia; Martin B. Leon; Brian Lima; Bruce W. Lytle; Michael J. Mack; Michael J. Reardon; T. Brett Reece; G. Russell Reiss; Eric E. Roselli; Craig R. Smith; Vinod H. Thourani; E. Murat Tuzcu